These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17699305)

  • 21. Mycophenolate mofetil-based immunosuppressive minimization and withdrawal strategies in renal transplantation: possible risks and benefits.
    Meier-Kriesche HU
    Curr Opin Nephrol Hypertens; 2006 Jun; 15 Suppl 1():S1-5. PubMed ID: 16829733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
    Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S;
    Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mycophenolate approval provides new option for organ-rejection prevention.
    Am J Health Syst Pharm; 1995 Oct; 52(19):2078. PubMed ID: 8535937
    [No Abstract]   [Full Text] [Related]  

  • 24. Mycophenolate mofetil vs. sirolimus in kidney transplant recipients receiving tacrolimus-based immunosuppressive regimen.
    Sampaio EL; Pinheiro-Machado PG; Garcia R; Felipe CR; Park SI; Casarini DE; Moreira S; Franco MF; Tedesco-Silva H; Medina-Pestana JO
    Clin Transplant; 2008; 22(2):141-9. PubMed ID: 18339132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids.
    Bunnapradist S; Daswani A; Takemoto SK
    Transplantation; 2003 Jul; 76(1):10-5. PubMed ID: 12865780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steroid avoidance or withdrawal after kidney transplantation: a balancing act.
    Sprangers B; Vanrenterghem Y
    Transplantation; 2010 Aug; 90(4):350-2. PubMed ID: 20548264
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term results of mycophenolate mofetil as part of immunosuppressive induction therapy after liver transplantation.
    Langrehr JM; Klupp J; Glanemann M; Junge G; Pfitzmann R; Bahra M; Radtke C; Neumann U; Neuhaus R; Neuhaus P
    Clin Transplant; 2006; 20(3):272-83. PubMed ID: 16824141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FK 506 prevents islet xenograft rejection: a study in the pig-to-rat model.
    Song Z; Wennberg L; Bennet W; Sundberg B; Groth CG; Korsgren O
    Transplant Proc; 1999; 31(1-2):981. PubMed ID: 10083437
    [No Abstract]   [Full Text] [Related]  

  • 29. Corticosteroid withdrawal under tacrolimus primary and rescue therapy in renal transplantation: the Chicago experience.
    Woodle ES; Buell J; Siegel C; Kulkarni S; Kopelan A; Grewal HP
    Transplant Proc; 1999 Nov; 31(7A):84S-85S. PubMed ID: 10576053
    [No Abstract]   [Full Text] [Related]  

  • 30. Risk of adrenal insufficiency with steroid maintenance therapy in renal transplantation.
    Boots JM; van den Ham EC; Christiaans MH; van Hooff JP
    Transplant Proc; 2002 Aug; 34(5):1696-7. PubMed ID: 12176541
    [No Abstract]   [Full Text] [Related]  

  • 31. Outcomes of African-American kidney-transplant recipients treated with sirolimus, tacrolimus, and corticosteroids.
    Egidi MF; Gaber AO
    Transplantation; 2003 Feb; 75(4):572; author reply 573. PubMed ID: 12605133
    [No Abstract]   [Full Text] [Related]  

  • 32. Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes?
    Byrne R; Yost SE; Kaplan B
    Clin Pharmacol Ther; 2011 Aug; 90(2):204-6. PubMed ID: 21772295
    [No Abstract]   [Full Text] [Related]  

  • 33. Can we maintain immunosuppression avoiding nephrotoxic agents in pancreas transplantation?
    Kandaswamy R; Dunn T; Humar A; Sutherland DE
    Transplant Proc; 2008 Mar; 40(2):516-7. PubMed ID: 18374118
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term results of cyclosporine monotherapy in renal transplantation.
    Kim HC; Chang KJ; Kwon JK; Park SB; Cho WH; Park CH
    Transplant Proc; 1998 Nov; 30(7):3539-40. PubMed ID: 9838550
    [No Abstract]   [Full Text] [Related]  

  • 35. One-year follow-up of a large European trial comparing dual versus triple tacrolimus-based immunosuppressive regimens following renal transplantation.
    Calconi G; Vianello A;
    Transplant Proc; 2001; 33(1-2):1021-4. PubMed ID: 11267173
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunosuppressant substitutes in liver transplantation.
    Ascher NL
    Lancet; 2001 Feb; 357(9256):571-2. PubMed ID: 11558477
    [No Abstract]   [Full Text] [Related]  

  • 37. Patients with high cholesterol levels benefit most from early withdrawal of corticosteroids.
    Rigotti P;
    Transplant Proc; 2002 Aug; 34(5):1797-8. PubMed ID: 12176581
    [No Abstract]   [Full Text] [Related]  

  • 38. Bullous pemphigoid associated with acute renal allograft rejection.
    Sofi AA; Gottwald L; Bohman K; Kaw D
    Transplantation; 2010 Feb; 89(3):368-9. PubMed ID: 20145531
    [No Abstract]   [Full Text] [Related]  

  • 39. Progressive multifocal leukoencephalopathy in a kidney transplant recipient after conversion to mycophenolic acid therapy.
    Manfro RC; Vedolin L; Cantarelli M; Oppitz P; Antunes AC; Rieder CR
    Transpl Infect Dis; 2009 Apr; 11(2):189-90. PubMed ID: 19210690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunomodulation in penetrating keratoplasty. Current status and perspectives].
    Pleyer U
    Ophthalmologe; 2003 Dec; 100(12):1036-44. PubMed ID: 14704816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.